We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+8.52%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$442M
AUM Growth
-$64.6M
(-13%)
Cap. Flow
-$69.8M
Cap. Flow
% of AUM
-15.79%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
735
New
90
Increased
155
Reduced
200
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vale
VALE
|
+$11.5M |
| 2 |
iShares MSCI Taiwan ETF
EWT
|
+$10.7M |
| 3 |
TechnipFMC
FTI
|
+$9.37M |
| 4 |
Canadian Imperial Bank of Commerce
CM
|
+$9.24M |
| 5 |
DB.RT
Deutsche Bank Aktiengesellschaft
DB.RT
|
+$6.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$29M |
| 2 |
UBS Group
UBS
|
+$13.1M |
| 3 |
United States Oil Fund
USO
|
+$8.92M |
| 4 |
Illumina
ILMN
|
+$7.05M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$6.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.88% |
| 2 | Consumer Discretionary | 10.22% |
| 3 | Technology | 8.93% |
| 4 | Materials | 6.92% |
| 5 | Communication Services | 4.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
iShares MSCI Peru and Global Exposure ETF
EPU
$534M
| $3.88M | 0.88% |
113,801
+113,795
| +1,896,583% | +$3.91M |
|
27
iShares MSCI Malaysia ETF
EWM
$305M
| $3.84M | 0.87% |
126,003
+122,003
| +3,050% | +$3.62M |
|
28
AbbVie
ABBV
$458B
| $3.46M | 0.78% |
53,080
+46,110
| +662% | +$2.9M |
|
29
Darden Restaurants
DRI
$22.5B
| $3.45M | 0.78% |
41,263
-11,588
| -22% | -$868K |
|
30
Banco Santander
SAN
$194B
| $3.44M | 0.78% |
592,006
+358,784
| +154% | +$1.93M |
|
31
AT&T
T
$165B
| $3.33M | 0.75% |
+106,123
| New | +$3.34M |
|
32
Intel
INTC
$466B
| $3.28M | 0.74% |
91,029
+88,392
| +3,352% | +$3.2M |
|
|
33
PUT
UBS Group
UBS
$170B
| $3.13M | 0.71% |
44,562
+559
| +1% | +$9K |
|
34
Logitech
LOGI
$15.2B
| $3.02M | 0.68% |
94,796
+22,568
| +31% | +$649K |
|
35
Applied Materials
AMAT
$426B
| $2.98M | 0.67% |
76,687
-52,744
| -41% | -$1.89M |
|
36
Western Digital
WDC
$179B
| $2.95M | 0.67% |
47,312
+46,695
| +7,568% | +$2.68M |
|
37
Meta Platforms (Facebook)
META
$1.51T
| $2.93M | 0.66% |
20,598
-17,089
| -45% | -$2.28M |
|
38
Abercrombie & Fitch
ANF
$4.17B
| $2.92M | 0.66% |
244,402
+148,702
| +155% | +$1.77M |
|
39
KLA
KLAC
$275B
| $2.92M | 0.66% |
306,670
+304,510
| +14,098% | +$2.68M |
|
|
VMW
40
DELISTED
VMware, Inc
VMW
| $2.87M | 0.65% |
31,198
+30,548
| +4,700% | +$2.69M |
|
41
Southern Company
SO
$110B
| $2.86M | 0.65% |
57,533
-1,448
| -2% | -$71.6K |
|
42
UGI
UGI
$8B
| $2.83M | 0.64% |
57,386
-30,913
| -35% | -$1.47M |
|
|
BCR
43
DELISTED
CR Bard Inc.
BCR
| $2.8M | 0.63% |
11,282
-7,347
| -39% | -$1.77M |
|
44
Hershey
HSY
$35.4B
| $2.8M | 0.63% |
25,634
+25,510
| +20,573% | +$2.74M |
|
45
Microchip Technology
MCHP
$42.8B
| $2.79M | 0.63% |
75,660
-48,208
| -39% | -$1.7M |
|
46
HCA Healthcare
HCA
$84.8B
| $2.79M | 0.63% |
+31,322
| New | +$2.61M |
|
47
TJX Companies
TJX
$170B
| $2.78M | 0.63% |
+70,360
| New | +$2.71M |
|
48
Broadcom
AVGO
$1.82T
| $2.78M | 0.63% |
126,940
-114,110
| -47% | -$2.35M |
|
49
Celanese
CE
$5.09B
| $2.77M | 0.63% |
30,813
+30,812
| +3,081,200% | +$2.69M |
|
50
Lear
LEA
$7.19B
| $2.77M | 0.63% |
19,533
+19,532
| +1,953,200% | +$2.77M |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q1 2017 Portfolio in Review
As of Q1 2017, Exane Derivatives held 735 positions worth $442M, down 13% from $507M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Exane Derivatives withdrew a net $69.8M in Q1 2017, closing 165 positions and reducing 200 holdings. Its most notable exit was UBS Group, an estimated $13.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Exane Derivatives opened a new position in Vale worth $11M.
- Exane Derivatives's largest Q1 2017 buy was Vale: 1,153,404 shares worth $11M.
- Exane Derivatives added most to iShares MSCI Taiwan ETF in Q1 2017, an estimated $10.7M increase.
- Exane Derivatives's biggest Q1 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $29M.
- Exane Derivatives fully exited UBS Group in Q1 2017, selling an estimated $13.1M.
- Exane Derivatives's ten largest holdings make up 35% of its $442M portfolio in Q1 2017.
- Exane Derivatives opened 90 new positions and closed 165 in Q1 2017.
- Exane Derivatives's portfolio value fell 13% quarter-over-quarter to $442M.
Based on Exane Derivatives's 13F filing for Q1 2017, filed 28 Apr 2017.